for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up
Company News

REFILE-CureVac to start global late-stage trial for COVID-19 vaccine in fourth quarter

(Refiles to correct Reuters Instrument Code)

Sept 29 (Reuters) - Germany’s CureVac NV said on Tuesday it has started a mid-stage study testing its experimental coronavirus vaccine and plans to begin a much larger trial in the fourth quarter. (Reporting by Trisha Roy in Bengaluru; Editing by Sriraj Kalluvila)

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up